Neurology
Initial treatment of convulsive status epilepticus
IV benzodiazepine or IM midazolam
Treatment of suspected giant cell arteritis
Immediate high-dose glucocorticoids
Hemoglobin transfusion threshold for most patients
<7 g/dL
First lab test for thyroid nodule
TSH level
Effective cervical cancer prevention
HPV vaccination
Initial treatment of ocular and mild generalized myasthenia
Pyridostigmine
Most specific serologic test for RA
Anti–cyclic citrullinated peptide antibody
Warfarin-related life-threatening bleeding treatment
Four-factor PCC
Initial test for suspected acromegaly
IGF-1 level
Genetic testing for metastatic prostate cancer
Germline variant (including BRCA) and somatic mutation testing
Complete myelitis, no CSF oligoclonal bands or IgG index, no brain MRI lesions
Idiopathic transverse myelitis
Preferred initial monotherapy for RA
Methotrexate
Acute promyelocytic leukemia treatment
All-trans retinoic acid and arsenic trioxide
Treatment of macroprolactinoma
Dopamine agonist
Testing for all patients with metastatic NSCLC to guide therapy
PD-L1 expression
Antibody test in myasthenia gravis with weakness of cervical extension
Anti–muscle-specific tyrosine kinase (MuSK)
Most effective maintenance therapy in granulomatosis with polyangiitis
Rituximab
Treatment of complement-mediated HUS
Eculizumab
Initial localization study of choice for primary aldosteronism
Dedicated adrenal CT
Molecular analysis for all metastatic colorectal cancer
KRAS, NRAS, BRAF, mismatch repair genes; HER2 amplification status
Management of unceasing convulsive status epilepticus after IV benzodiazepine and ASM
Intubation; anesthetically induced coma for 24-48 h (propofol, midazolam, or pentobarbital)
Acute severe myopathy and anti–HMG Co-A reductase antibodies
Immune-mediated necrotizing myopathy
Two main causes of kidney disease in MM
Hypercalcemia and cast nephropathy
Diagnosis suggested by hyperthyroidism, elevated TSH, and elevated free T4
TSH-secreting pituitary tumor
Effectiveness of current immunotherapies for mismatch repair-proficient colorectal cancers
Ineffective